The levels of evidence for how we treat our patients in clinical practice is often low. This is mostly due to the fact that limited data is often collected from studies of small patient populations affected with various diseases or conditions. We are often relegated to providing the best care that we can, using information extrapolated from treatments used in humans (or other species) and applying it in our small animal patients.
Therapeutic options for the feline can prove to be even more challenging due to the adverse effects they may have in cats, the difficult dosing, and patient compliance in taking these various medications. Furthermore, we are all familiar with the fact that, periodically, there may be reduced availability of certain commonly used drugs. This can really complicate the management of our feline patients.
A recently published paper looked at a variety of medications and their use in the feline species. These include new and emerging therapies as well as novel uses for other drugs that are more familiar to us.
In my recent EBU, available for viewing on demand, the focus is on antibiotics and antivirals. The drugs discussed include:
View it in the Evidence Based Updates (running time 15 mins). (Approved for CE credit in New York and by the NJVMA, pending approval for CE credit by AAVSB RACE).
Please login and post any questions or comments you have on this topic!
